Kirsebom & Richter et al. report that levels of the CSF synapse markers neurogranin and BACE1 remain stable in Alzheimer’s disease A/T/N subgroups, even when progressing to dementia. This evidence concerns the gene NRGN and early-onset autosomal dominant Alzheimer disease.